Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||
| Net Income | -5,392 | -31,700 | -41,860 |
| Depreciation Amortization | 1,012 | 4,430 | 3,830 |
| Accounts receivable | -978 | N/A | N/A |
| Accounts payable and accrued liabilities | -594 | N/A | N/A |
| Other Working Capital | 779 | 4,200 | 8,170 |
| Other Operating Activity | 1,577 | 2,240 | 680 |
| Operating Cash Flow | $-3,596 | $-20,830 | $-29,180 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -417 | -5,500 | -5,830 |
| Investing Cash Flow | $-417 | $-5,500 | $-5,830 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 7,500 | N/A | N/A |
| Common Stock Issued | 1 | N/A | N/A |
| Other Financing Activity | 0 | 21,030 | 40,170 |
| Financing Cash Flow | $7,501 | $21,030 | $40,170 |
| Beginning Cash Position | 7,077 | 12,380 | 7,240 |
| End Cash Position | 10,565 | 7,070 | 12,380 |
| Net Cash Flow | $3,488 | $-5,300 | $5,140 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,596 | -20,830 | -29,180 |
| Capital Expenditure | -417 | N/A | N/A |
| Free Cash Flow | -4,013 | -20,830 | -29,180 |